rinvoq
abbvie deutschland gmbh & co. kg - upadacitinib - arthritis, rheumatoid - immunszuppresszánsok - rheumatoid arthritisrinvoq is indicated for the treatment of moderate to severe active rheumatoid arthritis in adult patients who have responded inadequately to, or who are intolerant to one or more disease-modifying anti-rheumatic drugs (dmards). rinvoq may be used as monotherapy or in combination with methotrexate. psoriatic arthritisrinvoq is indicated for the treatment of active psoriatic arthritis in adult patients who have responded inadequately to, or who are intolerant to one or more dmards. rinvoq may be used as monotherapy or in combination with methotrexate. axial spondyloarthritisnon-radiographic axial spondyloarthritis (nr-axspa)rinvoq is indicated for the treatment of active non-radiographic axial spondyloarthritis in adult patients with objective signs of inflammation as indicated by elevated c-reactive protein (crp) and/or magnetic resonance imaging (mri), who have responded inadequately to nonsteroidal anti-inflammatory drugs (nsaids). ankylosing spondylitis (as, radiographic axial spondyloarthritis)rinvoq is indicated for the treatment of active ankylosing spondylitis in adult patients who have responded inadequately to conventional therapy. atopic dermatitisrinvoq is indicated for the treatment of moderate to severe atopic dermatitis in adults and adolescents 12 years and older who are candidates for systemic therapy. ulcerative colitisrinvoq is indicated for the treatment of adult patients with moderately to severely active ulcerative colitis who have had an inadequate response, lost response or were intolerant to either conventional therapy or a biologic agent. crohn’s diseaserinvoq is indicated for the treatment of adult patients with moderately to severely active crohn’s disease who have had an inadequate response, lost response or were intolerant to either conventional therapy or a biologic agent.
epirubicin accord 2 mg/ml oldatos injekció vagy infúzió
accord healthcare polska sp. z o.o. - epirubicin -
flumazenil pharmaselect 0,1 mg/ml oldatos injekció/koncentrátum oldatos infúzióhoz
pharmaselect gmbh - flumazenil -
cytarabine accord 100 mg/ml oldatos injekció vagy infúzió
accord healthcare polska sp. z o.o. - citarabin -
ciprofloxacin kabi 200 mg/100 ml oldatos infúzió
fresenius kabi deutschland gmbh - a ciprofloxacin -
ciprofloxacin kabi 400 mg/200 ml oldatos infúzió
fresenius kabi deutschland gmbh - a ciprofloxacin -
vopregin 200 mg por oldatos infúzióhoz
egis gyógyszergyár zrt. - vorikonazol -
fluorescite 100 mg/ml oldatos injekció
alcon hungária kft. - fluoreszcein -
irinotecan mylan pharma 20 mg/ml koncentrátum oldatos infúzióhoz
mylan s.a.s. - irinotecan -
irinotecan fresenius 20 mg/ml koncentrátum oldatos infúzióhoz
fresenius kabi hungary kft. - irinotecan -